KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement Jan 25, 2023 7:01am EST
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference Nov 21, 2022 7:01am EST
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals Nov 08, 2022 7:01am EST
KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022 Oct 26, 2022 4:01pm EDT
KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs Oct 12, 2022 7:01am EDT
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium Oct 05, 2022 7:01am EDT
KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference Aug 04, 2022 4:01pm EDT
